RevBio Awarded a $3.4 Million NIH Grant for Its Novel Regenerative Bone Adhesive to Treat Complex Fractures
/
DateOct 06 2023
This Grant will Fund the Company’s Translational Research Activities Through the Completion of a Pilot Clinical Trial. LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has... Read More →

















